Zi‐Niu Ding

机构：Sichuan Cancer Hospital, Qilu Hospital of Shandong University · ORCID：0000-0001-8995-6612

发表论文 69 篇 · 总被引 760 次 · h-index 16

代表论文

Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis (2024 · The Oncologist · 被引 26)
A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients (2023 · Biomarker Research · 被引 21)
DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression (2024 · Cell Death and Disease · 被引 11)
Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism (2025 · Cell Death Discovery · 被引 10)
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis (2024 · Expert Review of Anticancer Therapy · 被引 9)
Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis (2023 · Expert Review of Gastroenterology & Hepatology · 被引 8)